Usage of the Python Programming Language on the CMS Experiment

por Wilkinson, R, Hegner, B
Publicado 2009

Simulating the Endcap Muon CSC System in ORCA

por Wilkinson, R, Cox, P T
Publicado 2001

Immune reconstitution disease associated with parasitic infections following antiretroviral treatment

por LAWN, S D, WILKINSON, R J
Publicado 2006

Proceedings: Toxic effect of N-methyl-N-nitrosourea on normal and transformed cells.

por Wilkinson, R., Nias, A. H.
Publicado 1974

Using Python for Job Configuration in CMS

por Wilkinson, R, Hegner, B, Jones, C D
Publicado 2009

P.51 What a difference a year makes! Anaesthesia for category 1 caesarean section during the COVID-19 pandemic

por Wilkinson, R., Johnson, P., Entwistle, M., McNamara, H.M.
Publicado 2021

The GIOD Project-Globally Interconnected Object Databases

por Bunn, J J, Holtman, K, Newman, H B, Wilkinson, R P
Publicado 2001

The ongoing challenge of latent tuberculosis

por Esmail, H., Barry, C. E., Young, D. B., Wilkinson, R. J.
Publicado 2014

United we thrive: friendship and subsequent physical, behavioural and psychosocial health in older adults (an outcome-wide longitudinal approach)

por Kim, E. S., Chopik, W. J., Chen, Y., Wilkinson, R., VanderWeele, T. J.
Publicado 2023

Exact Equations for SIR Epidemics on Tree Graphs

por Sharkey, K. J., Kiss, I. Z., Wilkinson, R. R., Simon, P. L.
Publicado 2013

Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype

por Angell, H K, Gray, N, Womack, C, Pritchard, D I, Wilkinson, R W, Cumberbatch, M
Publicado 2013

Alcohol Text Messages: A Developmental Study

por Robinson, Maryanne, Wilkinson, R. B., Fletcher, R., Bruno, R., Baker, A. L., Maher, L., Wroe, J., Dunlop, A. J.
Publicado 2017

A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1

por Wilkinson, R W, Ross, E L, Lee-MacAry, A E, Laylor, R, Burchell, J, Taylor-Papadimitriou, J, Snary, D
Publicado 2000

The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models

por Holt, S V, Logié, A, Odedra, R, Heier, A, Heaton, S P, Alferez, D, Davies, B R, Wilkinson, R W, Smith, P D
Publicado 2012

Diagnostic radiation procedures and risk of prostate cancer

por Myles, P, Evans, S, Lophatananon, A, Dimitropoulou, P, Easton, D, Key, T, Pocock, R, Dearnaley, D, Guy, M, Edwards, S, O'Brien, L, Gehr-Swain, B, Hall, A, Wilkinson, R, Eeles, R, Muir, K
Publicado 2008

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

por Kote-Jarai, Z, Leongamornlert, D, Saunders, E, Tymrakiewicz, M, Castro, E, Mahmud, N, Guy, M, Edwards, S, O'Brien, L, Sawyer, E, Hall, A, Wilkinson, R, Dadaev, T, Goh, C, Easton, D, Goldgar, D, Eeles, R
Publicado 2011

Germline BRCA1 mutations increase prostate cancer risk

por Leongamornlert, D, Mahmud, N, Tymrakiewicz, M, Saunders, E, Dadaev, T, Castro, E, Goh, C, Govindasami, K, Guy, M, O'Brien, L, Sawyer, E, Hall, A, Wilkinson, R, Easton, D, Goldgar, D, Eeles, R, Kote-Jarai, Z
Publicado 2012

Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease

por Leongamornlert, D, Saunders, E, Dadaev, T, Tymrakiewicz, M, Goh, C, Jugurnauth-Little, S, Kozarewa, I, Fenwick, K, Assiotis, I, Barrowdale, D, Govindasami, K, Guy, M, Sawyer, E, Wilkinson, R, Antoniou, A C, Eeles, R, Kote-Jarai, Z
Publicado 2014